Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go:
Extended
investment:
£10,000
Felcana is a patented Eco-system of connected devices: Helix, Home Hub, Micro-Location Beacons and the Felcana application which work together to monitor the pet's (cat or dogs) well-being. This Digital Pet Health Platform tracks pet's behaviour and provides the vet, rich data leading to faster diagnosis and faster treatment. Felcana has been developed by a world-class team of vets and engineers and, it has been designed and tested by using the latest materials, designs, and techniques. Felcana has won the Design Spark Award in 2017. It is making unique partnerships with leading pet industries and the UK's largest pet health plan provider, the world's top-ranked vet school and The Royal Veterinary College. The new investment will enable it to grow consumer reach and accelerate its sales.
days to go:
Expired
investment:
£343,926
Vaboo is a customisable perks and engagement platform for the private rented sector. The platform allows clients to enhance their brand image and add value to their service through engaging communication, giveaways, and prize draws, designed to attract customers to the platform on a regular basis. Addressing core problems of the sector, Vaboo not only helps clients built their brand value, it also offers them a competitive edge in the market. By April 2019, 350+ agency branches will have brought 50,000+ renters on to the platform. Moreover, Vaboo is estimated to achieve at least a 10% market share (approx. 2000 branches) which will generate annual recurring revenues of over £4m. With the fund raised, Vaboo will focus on team expansion, product development, and sales.
days to go:
Expired
investment:
£172,077
Using the latest in technology to recycle a wider range of plastics with environmentally friendlier results. Recycling Technologies have created the RT7000, a machine that processes plastic waste and recycles it into Plaxx®. This new product can be used in wax products, as well as new plastic. Plastic products that are generally considered non-recyclable such as food trays and pouches, films and crisps packets can be processed by the company's machine.
Contributions in the funding round will be invested towards developing around 200 RT7000 machines per annum at the company's manufacturing site, with a 2027 target of 1300 RT7000s to be leased to other businesses. Recycling Technologies has predicted that that from 10m tonnes of plastic, 7m tonnes will be processed into Plaxx®. Furthermore, funds will be allocated to expand the team and Binn Ecopark site, as well as run a 24/7 trial on their new plant.
days to go:
Expired
investment:
£1,938,060
Q Doctor aims at changing the NHS care delivery with the help of video consulting to benefit patients and clinicians. The company is focusing on delivering a model that keeps modernised NHS care free of charge for the patients. The video solution plugs NHS clinicians to the existing NHS infrastructure and allows them to connect to the NHS patients digitally. With the proceeds, Q Doctor will fulfil its strategy for 2020. It will deploy the funds into labour, development, operations, marketing, and contingency funds.
days to go:
Expired
investment:
£1,386,200
Fobo is one of the worlds first Proactive Hybrid Dating business and thousands have already joined.By merging together social media, online dating and offline events we have created a dating business which guarantees 24/7 engagement, free monthly group singles events and the opportunity to expand your singles friends network both online and offline.
days to go:
Expired
investment:
£27,339
